03.06.2013 Views

Registration document 2011 - tota - Total.com

Registration document 2011 - tota - Total.com

Registration document 2011 - tota - Total.com

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

For the year ended December 31, 2010 Adjusted Adjustments (a) Consolidated<br />

(M€) statement<br />

of in<strong>com</strong>e<br />

Sales 159,269 - 159,269<br />

Excise taxes (18,793) - (18,793)<br />

Revenues from sales 140,476 - 140,476<br />

Purchases, net of inventory variation (94,286) 1,115 (93,171)<br />

Other operating expenses (19,035) (100) (19,135)<br />

Exploration costs (864) - (864)<br />

Depreciation, depletion and amortization of tangible assets and mineral interests (7,005) (1,416) (8,421)<br />

Other in<strong>com</strong>e 524 872 1,396<br />

Other expense (346) (554) (900)<br />

Financial interest on debt (465) - (465)<br />

Financial in<strong>com</strong>e from marketable securities & cash equivalents 131 - 131<br />

Cost of net debt (334) - (334)<br />

Other financial in<strong>com</strong>e 442 - 442<br />

Other financial expense (407) - (407)<br />

Equity in in<strong>com</strong>e (loss) of affiliates 2,003 (50) 1,953<br />

In<strong>com</strong>e taxes (10,646) 418 (10,228)<br />

Consolidated net in<strong>com</strong>e 10,522 285 10,807<br />

Group share 10,288 283 10,571<br />

Non-controlling interests 234 2 236<br />

(a) Adjustments include special items, inventory valuation effect and, until June 30, 2010, equity share of adjustments related to Sanofi.<br />

For the year ended December 31, 2009 Adjusted Adjustments (a) Consolidated<br />

(M€) statement<br />

of in<strong>com</strong>e<br />

Sales 131,327 - 131,327<br />

Excise taxes (19,174) - (19,174)<br />

Revenues from sales 112,153 - 112,153<br />

Purchases, net of inventory variation (73,263) 2,205 (71,058)<br />

Other operating expenses (18,271) (320) (18,591)<br />

Exploration costs (698) - (698)<br />

Depreciation, depletion and amortization of tangible assets and mineral interests (6,291) (391) (6,682)<br />

Other in<strong>com</strong>e 131 183 314<br />

Other expense (315) (285) (600)<br />

Financial interest on debt (530) - (530)<br />

Financial in<strong>com</strong>e from marketable securities & cash equivalents 132 - 132<br />

Cost of net debt (398) - (398)<br />

Other financial in<strong>com</strong>e 643 - 643<br />

Other financial expense (345) - (345)<br />

Equity in in<strong>com</strong>e (loss) of affiliates 1,918 (276) 1,642<br />

In<strong>com</strong>e taxes (7,302) (449) (7,751)<br />

Consolidated net in<strong>com</strong>e 7,962 667 8,629<br />

Group share 7,784 663 8,447<br />

Non-controlling interests 178 4 182<br />

(a) Adjustments include special items, inventory valuation effect and equity share of adjustments related to Sanofi.<br />

Consolidated Financial Statements 9<br />

Notes to the Consolidated Financial Statements<br />

<strong>Registration</strong> Document <strong>2011</strong>. TOTAL<br />

205

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!